5AM Venture Management, LLC

Holdings as of 2026-06-30, filed 2026-08-14

This is history, not a current position. These holdings describe 2026-06-30, and the report became public 45 days later. The portfolio has changed since.

Aggregates

computed from the positions below
Positions reported
16
Value reported by manager
$287.9M
Sum of our stored positions
$287.9M
should match the line above
Disclosure lag
45 d
quarter end to filing
Top 5 concentration
52.1%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls

Positions

16 largest shown
IssuerClassValueSharesTypeCUSIP
MAPLIGHT THERAPEUTICS INCCOM$34M950,01156565P103
TYRA BIOSCIENCES INCCOM$32.9M1,029,29890240B106
ENTRADA THERAPEUTICS INCCOM$29.9M4,056,37929384C108
PHARVARIS N VCOM$27.6M797,600N69605108
CAMP4 THERAPEUTICS CORPCOM$25.6M5,869,09113463J101
ARTIVA BIOTHERAPEUTICS INCCOM$22.8M2,353,30404317A107
TECTONIC THERAPEUTIC INCCOM$20.9M606,660878972108
ZENTALIS PHARMACEUTICALS INCCOM$19.1M3,947,91398943L107
CELLDEX THERAPEUTICS INC NEWCOM NEW$18.5M497,27015117B202
EYEPOINT INCCOM NEW$15M1,050,00030233G209
BIOHAVEN LTDCOM$11M738,972G1110E107
SURROZEN INCCOM NEW$7M271,25086889P208
SKYE BIOSCIENCE INCCOM NEW$6.7M9,681,76383086J200
ALX ONCOLOGY HLDGS INCCOM$6.3M3,057,32500166B105
PROTARA THERAPEUTICS INCCOM STK$5.2M1,369,78274365U107
SILENCE THERAPEUTICS PLCADS$5.2M476,20082686Q101
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.

Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-14